Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream

A. Weinstock, Martin; Soe Thwin, Soe; A. Siegel, Julia; Marcolivio, Kimberly; D. Means, Alexander; Leader, Nicholas; M. Shaw, Fiona; J. Hogan, Daniel; Eilers, David; M. Swetter, Susan; C. Chen, Suephy; E. Jacob, Sharon; M. Warshaw, Erin; P. Stricklin, George; P. Dellavalle, Robert; Sidhu‐Malik, Navjeet; Konnikov, Nellie; P. Werth, Victoria; Keri, Jonette; Robinson‐Bostom, Leslie; Ringer, Robert; Lew, Robert; Ferguson, Ryan; J. DiGiovanna, John; D. Huang, Grant; the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group, for

doi:10.1001/jamadermatol.2017.3631

Public

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream

Published in JAMA Dermatology • Jan 3, 2018

Authors:

Martin A. Weinstock

Soe Soe Thwin

Julia A. Siegel

Abstract

Importance: Keratinocyte carcinoma (ie, cutaneous basal and squamous cell carcinoma) is the most common cancer in the United States. Objective: To determine whether topical fluorouracil could prevent surgically treated keratinocyte carcinoma. Design, Setting, and Participants: The Veterans Affairs K...

Subject

Medicine

Veterans Affairs

Fluorouracil

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!